Clinics in Dermatology
Volume 24, Issue 6 , Pages 470-481 , November 2006

Neutrophilic dermatoses

  • Arturo P. Saavedra, MD

      Affiliations

    • Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA
    • Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 732 6510.
    • ,
  • Susanne Christine Kovacs, MD

      Affiliations

    • Department of Dermatology, Tufts University School of Medicine, Boston, MA 01805, USA
    • Department of Dermatology, Lahey Clinic, Burlington, MA 01805, USA
    • ,
  • Samuel L. Moschella, MD

      Affiliations

    • Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA
    • Department of Dermatology, Lahey Clinic, Burlington, MA 01805, USA

References 

  1. Jorizzo JL, Solomon AR, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol. 1988;19:983–1005
  2. Su WPD, Liu HNH. Diagnostic criteria for Sweet's syndrome. Cutis. 1986;37:167–174
  3. Honigsmann H, Cohen PR, Wolff K. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Wien Klin Wochenschr. 1979;91:842–847
  4. Fett DL, Gibson LE, Su WPD. Sweet's syndrome: signs and symptoms and associated disorders. Mayo Clin Proc. 1995;70:234–240
  5. Vignon-Pennamen MD, Wallach D. Neutrophilic disease: a review of extracutaneous neutrophilic manifestations. Eur J Dermatol. 1996;5:449–455
  6. Moreland LW, et al. Acute febrile neutrophilic dermatosis (Sweet's syndrome): a review of the literature with emphasis on musculoskeletal manifestations. Semin Arthritis Rheum. 1988;17:143–155
  7. Krause RE, Schumacher HR. The arthritis of Sweet's syndrome. Arthritis Rheum. 1975;18:35–41
  8. Von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31:535–556
  9. Cohen PR, Holder WR, Tucker SB, et al. Sweet syndrome in patients with solid tumors. Cancer. 1993;72:2723–2731
  10. Gelfand JM, James WD. Sweet's syndrome. In: Treatment of skin disease. London: Mosby; 2002;p. 613–615
  11. Harary AM. Sweet's syndrome associated with rheumatoid arthritis. Arch Intern Med. 1983;143:1993–1995
  12. Goette DK. Sweet's syndrome in subacute cutaneous lupus erythematosus. Arch Dermatol. 1985;121:789–791
  13. Hou TY, et al. Sweet syndrome as an initial presentation in systemic lupus erythematosus: a case report and review of the literature. Lupus. 2005;14:399–402
  14. Choi JW, Chung KY. Sweet's syndrome with systemic lupus erythematosus and herpes zoster. Br J Dermatol. 1999;140:1169–1199
  15. Ramsey-Goldman R, et al. Hydralazine-induced lupus and Sweet's syndrome. Report and review of the literature. J Rheumatol. 1990;17:682–684
  16. Osawa H, et al. A case of Sjögren's syndrome associated with Sweet's syndrome. Clinical Rheumatol. 1997;16:101–105
  17. Astudillo L, et al. Sweet's syndrome revealing relapsing polychondritis. Int J Dermatol. 2004;43:720–722
  18. Elinav H, et al. The coexistence of Sweet's syndrome and Still's disease—is it merely a coincidence?. J Am Acad Dermatol. 2004;50:S90–S92
  19. Campos LMA, et al. Takayasu's arteritis with aortic aneurysm associated with Sweet's syndrome in childhood. Ann Rheum Dis. 2005;64:168–169
  20. Moschella SL. Neutrophilic dermatosis. In:  Bolognia J,  Jorizzo J,  Rapini R editor. Dermatology. London: Mosby; 2003;p. 411–423
  21. Jorizzo JL, Greer KE, Callen JP. Miscellaneous disorders with prominent features involving the skin and the joints. In:  Callen J,  Jorizzo J editor. Dermatologic signs of internal disease. Philadelphia: Saunders; 2003;p. 33–44
  22. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg. 2004;8:77–89
  23. Brocq L. Nouvelle contribution a l'etude du phagedenisme geometrique. Ann Dermatol Syphiligr. 1916;6:1–39
  24. Quimby SR, Gibson LE, Winkelmann RK. Superficial granulomatous pyoderma: clinicopathologic spectrum. Mayo Clin Proc. 1989;64:37–43
  25. Cairns BA, Herbst CA, Sartor BR, et al. Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg. 1994;129:769–772
  26. Yeaon HB, et al. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet. 2000;66:1443
  27. Noralane ML, et al. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72:611–615
  28. Callen JP. Pyoderma gangrenosum. Lancet. 1998;351:581–585
  29. Powell FC, Su WPD, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996;34:395–409
  30. Jolt PJA, et al. Pyoderma gangrenosum—clinical and laboratory findings in 15 patients with special reference to polyarthritis. Med. 1980;59:114–133
  31. Powell FC, et al. Pyoderma gangrenosum: a review of 86 patients. Quart Journal of Med. 1985;55:173–186
  32. Callen JP. Pyoderma gangrenosum and related disorders. Med Clin North Am. 1989;73:1247–1261
  33. Smith DL, White CR. Pyoderma gangrenosum in association with psoriatic arthritis. Arthritis Rheum. 1994;37:1258–1260
  34. Oliveiri I, et al. Pyoderma gangrenosum in associations with undifferentiated seronegative spondyloarthropathy. Arthritis Rheum. 1996;39:1062–1065
  35. Chow RKP, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol. 1996;34:1047–1060
  36. Wayte JA, et al. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy. Australas J Dermatol. 1995;36:21
  37. Urano S, Kodama H, Kato K, et al. Pyoderma gangrenosum with systemic involvement. J Dermatol. 1995;22:515–519
  38. Kaklamani VG, Vaviopoulos G, Kaklamanis PG. Behçet's disease. Semin Arthritis Rheum. 1988;27:197–217
  39. Moschella SL. Pyoderma gangrenosum: a patient successfully treated with intralesional steroids. Arch Dermatol. 1967;95:121–123
  40. Gupta AK, Shear NH, Sauder DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol. 1995;32:140–142
  41. Gerard JA, et al. Pyoderma gangrenosum: traitement par exchanges plamatiques (4 cas). Ann Med Interne (Paris). 1988;139:29
  42. Baumbauer R, et al. Drug resistant pyoderma gangrenosum successfully treated with therapeutic plasma exchange. Transfus Sci. 1989;10:349
  43. Sevila A, Morell A, Banuls J, et al. Neutrophilic eccrine hidradenitis in an HIV-infected patient. Int J Dermatol. 1996;35:651–652
  44. Fitzpatrick JE. The cutaneous histopathology of chemotherapeutic reactions. J Cutan Pathol. 1993;20:1
  45. Fiorillo L, et al. The pseudomonas hot-foot syndrome. N Engl J Med. 2002;345:335
  46. Pique E, Auilar A, Olivares M, et al. Idiopathic palmo-plantar hidradenitis: report of 3 cases and literature review. Dermatology. 1997;195:379–381
  47. Dne-Amitai D, Hodak E, Landau M, et al. Palmoplantar eccrine hidradenitis in children. Eur J Pediatr. 2001;160:189–191
  48. Schirmer M, Calamia KT, Direskeneli H. Ninth International Conference on Behçet's Disease, Seoul, Korea, May 27-29, 2000. J Rheumatol. 2001;28:636–639
  49. Arbesfeld SJ, Kurban AK. Behçet's disease. New perspectives on an enigmatic syndrome. J Am Acad Dermatol. 1988;19:767–779
  50. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engel J Med. 1999;341:1284–1291
  51. Hamza M. Forward. In: VIIth International Conference on Behçet's Disease. Tunis, Tunisia, October 10-11, 1996. Rev Rhum Engl Ed. 63:1996;p. 508
  52. Firestein GS, Gruber HE, Weisman MH, et al. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Am J Med. 1985;79:65–72
  53. Magro CM, Crowson AN. Cutaneous manifestations of Behçet's disease. Int J Dermatol. 1995;34:159–165
  54. Kallinowski B, Noldge G, Stiehl A. Crohn's disease with Behçet's syndrome like appearance: a case report. J Gastroenterol. 1994;32:642–644
  55. Ghate JV, Jorizzo JL. Behçet's disease and complex apthosis. J Am Acad Dermatol. 1999;40:1–18
  56. Benamour S, et al. Joint manifestations in Behçet's disease. A review of 340 cases. Rev Rhum. 1998;65:299–307
  57. Duzgun N, Ates A. Erosive arthritis in a patient with Behçet's disease. Rheumatol Int. 2003;23:265–267
  58. Jawad ASM, Goodwill CJ. Behçet's disease with erosive arthritis. Ann Rheum Dis. 1986;45:961–962
  59. Armas JB, et al. Atypical Behçet's disease with peripheral erosive arthropathy and pyoderma gangrenosum. Clin Exp Rheumatol. 1992;10:177–180
  60. Etaouil N, et al. Ankylosing spondylitis and Behçet's disease in combination. Two case reports. Joint Bone Spine. 2002;69:96–98
  61. Zizic TM, Stevens MB. The arthropathy of Behçet's disease. Johns Hopkins Med J. 1975;136:243–250
  62. Kaklamani VG, Kalsomines PG. Treatment of Behçet's disease—an update. Semin Arthritis Rheum. 2001;30:299–312
  63. Green J, Jorizzo Jl. Apthous stomatitis. Miscellaneous disorders with prominent features involving the skin and the joints. In:  Callen J,  Jorizzo J editor. Dermatologic signs of internal disease. Philadelphia: Saunders; 2003;p. 53–57
  64. Kennedy C. The spectrum of inflammatory skin disease following jejuno-ileal bypass for morbid obesity. Br J Dermatol. 1981;105:425–435
  65. Williams HJ, Samuelson CO, Zone JJ. Nodular nonsuppurative panniculitis associated with jejunoileal bypass surgery. Arch Dermatol. 1979;115:1091–1093
  66. Dickens CH, Seafarer JR. Bowel bypass syndrome. Arch Dermatol. 1979;115:837–839
  67. Jorrizzo JL, Apisarnthanarax P, Subert P, et al. Bowel bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Intern Med. 1983;143:457–461
  68. Ely PH. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol. 1908;2:473–487
  69. Wands JR, Lamont JT, Mann E, Isselbacher KJ. Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med. 1976;294:121–124
  70. Jorizzo JL, Schmalsteig FC, Dinehart SM, et al. Bowel-associated dermatosis-arthritis syndrome. Immune complex-mediated vessel damage and increased neutrophil migration. Arch Intern Med. 1984;144:738–740
  71. Magro Cm, Crowson AN. Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction reflecting systemic disease. J Cutan Pathol. 1998;25:215–221
  72. O'Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol. 1978;114:1061–1064
  73. Bergdahl K, et al. Pustulosis palmoplantaris and its relation to chronic multifocal osteomyelitis. Dermatologica. 1979;159:37
  74. Hradil E, et al. Skeletal involvement in pustulosis palmo-plantaris with special reference to the sternoclavicular joints. Acta Derm Venereol. 1988;68:65
  75. Baker H, Ryan TJ. Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol. 1968;80:771–776
  76. Farber EM, Nal L. Pustular psoriasis. Cutis. 1993;51:29–32
  77. Ryan TJ, Baker H. Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis: evaluation and prognosis based on the study of 104 cases. Br J Dermatol. 1969;81:134–145
  78. Elewski BE. Infliximab for the treatment of severe pustular psoriasis. J Am Acad Dermatol. 2002;47:796–797
  79. Benoit S, et al. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br J Dermatol. 2004;150:1009–1012
  80. Callen JP, Jackson JH. Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent. J Dermatolog Treat. 2005;15:350–352
  81. Trent JT, Kerdel FA. Successful treatment of von Zumbusch pustular psoriasis with infliximab. J Cutan Med Surg. 2004;8:224–228
  82. Sasaki T. A case with osteomyelitis of the bilateral clavicles associated with pustulosis palmaris et plantaris. Rinso Sei Keigara. 1967;2:333
  83. Akiyama T, et al. The relationship of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections. J Dermatol. 1995;22:930
  84. Nikkels AF, et al. Breaking the relentless course of Hallopeau's acrodermatitis by dapsone. Eur J Dermatol. 1999;9:126
  85. Kazinski K, Joyce KM, Hodson D. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of Hallopeau. J Drugs Dermatol. 2005;4:360–364
  86. Chalmers RG. Psoriasis. In: Evidence-based dermatology. London: BMJ; 2003;p. 226–252
  87. Wolff K. A contribution to the nosology of subcorneal pustular dermatosis (Sneddon-Wilkinson). Arch Klin Exp Dermatol. 1966;224:248
  88. Marsden JR, Millar LG. Pyoderma gangrenosum, subcorneal pustular dermatosis and IgA paraproteinemia. Br J Dermatol. 1986;114:125–129
  89. Kasha EE, Epinette WW. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) in association with a monoclonal IgA gammopathy: a report and review of the literature. J Am Acad Dermatol. 1988;19:854–858
  90. Sneddon IB, Wilkinson DS. Subcorneal pustular dermatosis. Br J Dermatol. 1956;68:385–392
  91. Olsen TG, et al. Subcorneal pustular dermatosis and crippling arthritis. Arch Dermatol. 1979;115:185–188
  92. Folkers E, Tafelkruyer J. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease)—therapeutic problems. Br J Dermatol. 1978;98:681–684
  93. Leavell UW, et al. Polymorphous eruption with arthritis. J Kentucky Med Assoc. 1970;68:149–153
  94. Weiner S. Subcorneal pustular dermatosis and rheumatoid arthritis. Arthritis Rheum. 1981;24:1213–1214
  95. Butt A, Bruge SM. Sneddon-Wilkinson disease in association with rheumatoid arthritis. Br J Dermatol. 1995;132:313
  96. Roger H, et al. Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: simultaneous remission of skin and joint involvements with dapsone treatment. Ann Rheum Dis. 1990;49:190–191
  97. Wallach D. Intraepidermal IgA pustulosis. J Am Acad Dermatol. 1993;27:993–1000

PII: S0738-081X(06)00101-5

doi: 10.1016/j.clindermatol.2006.07.009

Clinics in Dermatology
Volume 24, Issue 6 , Pages 470-481 , November 2006

Article Tools

* Image Usage & Resolution